Osimertinib significantly improved progression-free survival in patients with unresectable stage III non-small cell lung cancer
1. Treatment with osimertinib significantly improved progression-free survival, compared to...
Read More
Author: admin
Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colon Cancer
1. No disease recurrences were observed during the median follow-up time of 26.2 months. 2....
Read More
#VisualAbstract: Patient Education Program May Reduce Disability and Symptoms of Chronic Pain
1. Adults with chronic low back pain (CLBP) randomized into a 6-week pain intervention education...
Read More
Surgeon General Calls for Warning Labels on Social Media Sites
MONDAY, June 17, 2024 (HealthDay News) — The U.S. Surgeon General announced Monday that he...
Read More
Epilepsy Surgery for Neuroglial Tumors Shows Good Long-Term Outcomes
MONDAY, June 17, 2024 (HealthDay News) — Patients with neuroglial tumors are ideal epilepsy...
Read More
Bariatric Surgery Cuts Conversion to Diabetes Over Long-Term Follow-Up
MONDAY, June 17, 2024 (HealthDay News) — Bariatric surgery significantly decreases the...
Read More
Emotional Awareness and Expression Therapy Beneficial for Pain Relief
MONDAY, June 17, 2024 (HealthDay News) — For older patients with at least three months of...
Read More
Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive Ventilation
MONDAY, June 17, 2024 (HealthDay News) — Pantoprazole results in a significantly lower risk...
Read More
Survodutide Tied to Significant Improvement in Fatty Liver Disease
MONDAY, June 17, 2024 (HealthDay News) — Most patients taking survodutide, a dual agonist of...
Read More
Xylitol Linked to Incident Major Adverse Cardiovascular Event Risk
MONDAY, June 17, 2024 (HealthDay News) — Xylitol is associated with incident major adverse...
Read More
Teens, Young Adults Modify Electronic Nicotine Delivery Systems
MONDAY, June 17, 2024 (HealthDay News) — Adolescents and young adults (AYAs) are aware of...
Read More
Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose
MONDAY, June 17, 2024 (HealthDay News) — In the 12 months after a nonfatal overdose, few...
Read More
2008 to 2021 Saw Increase in Prevalence of Chronic HTN in Pregnancy
MONDAY, June 17, 2024 (HealthDay News) — For pregnant individuals, the prevalence of chronic...
Read More
CDC Warns of Salmonella Danger Posed by Pet Bearded Dragons
MONDAY, June 17, 2024 (HealthDay News) — In a health advisory issued Friday, the U.S....
Read More
Meal Replacement + Financial Incentives Beneficial for Teens With Obesity
MONDAY, June 17, 2024 (HealthDay News) — For adolescents with severe obesity, meal...
Read More
1999 to 2020 Saw Diet Quality Improve Among U.S. Adults
MONDAY, June 17, 2024 (HealthDay News) — From 1999 to 2020, diet quality improved among U.S....
Read More
Paternal Metformin Use Not Linked to Major Congenital Malformations
MONDAY, June 17, 2024 (HealthDay News) — Paternal use of metformin in monotherapy is not...
Read More
Quantifying the reduction of primary breast cancer associated with exercise
1. Across a follow-up period of approximately 5 years, there was a non-linear relationship between...
Read More[Development of an exercise program for sedentary behavior in desk workers].
The effects of lacking exercise due to increased sedentary behavior on physical and mental health are attracting attention. We developed an exercise program for sedentary behavior in desk workers and verified whether decreased...
Read MoreEffects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies.
Phosphodiesterase 2 (PDE2) regulates intracellular cyclic adenosine monophosphate and guanosine monophosphate (cAMP/cGMP) levels, which contribute to processes crucial for learning and memory. BI 474121, a potent and selective...
Read More